IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 204 filers reported holding IMMUNOGEN INC in Q4 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $460 | -68.2% | 29,000 | -62.1% | 0.00% | -66.7% |
| Q2 2023 | $1,445 | +48.7% | 76,600 | -69.7% | 0.01% | +500.0% |
| Q1 2023 | $972 | +132.5% | 253,200 | +200.0% | 0.00% | -50.0% |
| Q4 2022 | $418 | -99.9% | 84,400 | -36.1% | 0.00% | -33.3% |
| Q3 2022 | $630,000 | +6.1% | 132,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $594,000 | -2.5% | 132,000 | +3.1% | 0.00% | +50.0% |
| Q1 2022 | $609,000 | -35.8% | 128,000 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $949,000 | +35.2% | 128,000 | +3.3% | 0.00% | 0.0% |
| Q3 2021 | $702,000 | -17.4% | 123,900 | -4.0% | 0.00% | 0.0% |
| Q2 2021 | $850,000 | +1228.1% | 129,000 | +435.3% | 0.00% | – |
| Q3 2016 | $64,000 | -16.9% | 24,100 | -3.6% | 0.00% | – |
| Q2 2016 | $77,000 | -63.8% | 25,000 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $213,000 | -37.2% | 25,000 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $339,000 | +46.8% | 25,000 | +3.7% | 0.00% | +100.0% |
| Q3 2015 | $231,000 | – | 24,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |